Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity
about
Deprescribing versus continuation of chronic proton pump inhibitor use in adultsValidity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria.Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial.Little Evidence for Usefulness of Biomarkers for Predicting Successful Dose Reduction or Discontinuation of a Biologic Agent in Rheumatoid Arthritis: A Systematic Review.Low rates of biologic-free clinical disease activity index remission maintenance after biologic disease-modifying anti-rheumatic drug discontinuation while in remission in a Japanese multicentre rheumatoid arthritis registry.Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry.bDMARD Dose Reduction in Rheumatoid Arthritis: A Narrative Review with Systematic Literature Search.Withdrawal of biologic agents in rheumatoid arthritis: a systematic review and meta-analysis.Dosing down with biologic therapies: a systematic review and clinicians' perspective.Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature reviewOptimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?Biological tapering and sonographic flare in rheumatoid arthritis.Maintenance of Remission with Etanercept-DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis.Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis.Anti-TNF Withdrawal in Inflammatory Bowel Disease.Maintenance of low disease activity and remission with etanercept-disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: Subset analysis
P2860
Q24188083-DD68262D-C629-480D-9957-6043B438B543Q31122982-15BE3BA6-892A-40A3-8387-6794D71D32E2Q35348182-86257D89-7D83-4E76-903D-D22C35232992Q36151778-916340F3-E3C2-412A-A09D-88C9BC8F719DQ36573569-FCA9C8AC-2C07-48EF-AB83-0FA125E0C40CQ38598776-1C925FD2-8B0B-4CA6-B600-3DD47F4ED2CDQ38608695-1B2B55E1-0E70-4E26-97E9-62546B15EAE2Q38751251-F853EDAA-12A9-4B7A-BE66-7653DFFCA657Q38815746-A6C62865-2527-4A98-8CBB-186BC1674EE7Q39198863-7ECDBAD1-4D66-4830-ABB1-87D5C2FFF597Q42683547-FC4B9523-7C4C-450A-A97D-DF71F0E8CAB2Q47102960-83380054-0A16-4687-A5C6-5CD7C0E3301AQ47764977-BD7DC0AE-81F3-4D3E-AB21-611BE813561DQ53702206-AC9E9EB5-6E1F-41F1-B17C-D6A004832D0DQ55376762-66F08D92-C263-4F52-B6D5-00B48C60CA58Q55421713-98337347-36FA-4212-B5E7-5D3DB7BA3CA4Q58759283-667E4572-751B-425B-A746-85CA2E88CEBE
P2860
Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Down-titration and discontinua ...... ents with low disease activity
@ast
Down-titration and discontinua ...... ents with low disease activity
@en
Down-titration and discontinua ...... ents with low disease activity
@en-gb
Down-titration and discontinua ...... ents with low disease activity
@nl
type
label
Down-titration and discontinua ...... ents with low disease activity
@ast
Down-titration and discontinua ...... ents with low disease activity
@en
Down-titration and discontinua ...... ents with low disease activity
@en-gb
Down-titration and discontinua ...... ents with low disease activity
@nl
prefLabel
Down-titration and discontinua ...... ents with low disease activity
@ast
Down-titration and discontinua ...... ents with low disease activity
@en
Down-titration and discontinua ...... ents with low disease activity
@en-gb
Down-titration and discontinua ...... ents with low disease activity
@nl
P2093
P2860
P3181
P1476
Down-titration and discontinua ...... ents with low disease activity
@en
P2093
Aatke van der Maas
Bart(holomeus) JF van den Bemt
Johannes WJ Bijlsma
Noortje van Herwaarden
Wilco Jacobs
P2860
P3181
P356
10.1002/14651858.CD010455.PUB2
P577
2014-09-29T00:00:00Z